• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatrics . Household Transmission and Clinical Features of SARS-CoV-2 Infections

tetano

Editor, Senior Moderator
Pediatrics


. 2022 Feb 23;e2021054178.
doi: 10.1542/peds.2021-054178. Online ahead of print.
Household Transmission and Clinical Features of SARS-CoV-2 Infections


Huong Q McLean[SUP] 1 [/SUP], Carlos G Grijalva[SUP] 2 [/SUP], Kayla E Hanson[SUP] 1 [/SUP], Yuwei Zhu[SUP] 2 [/SUP], Jessica E Deyoe[SUP] 3 [/SUP], Jennifer K Meece[SUP] 1 [/SUP], Natasha B Halasa[SUP] 2 [/SUP], James D Chappell[SUP] 2 [/SUP], Alexandra M Mellis[SUP] 3 [/SUP], Carrie Reed[SUP] 3 [/SUP], Edward A Belongia[SUP] 1 [/SUP], H Keipp Talbot[SUP] 2 [/SUP], Melissa A Rolfes[SUP] 3 [/SUP]



Affiliations

Abstract

Objectives: Examine age differences in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission risk from primary cases and infection risk among household contacts and symptoms among those with SARS-CoV-2 infection.
Methods: People with SARS-CoV-2 infection in Nashville, Tennessee and central and western Wisconsin and their household contacts were followed daily for 14 days to ascertain symptoms and secondary transmission events. Households were enrolled between April 2020 and April 2021. Secondary infection risks (SIR) by age of the primary case and contacts were estimated using generalized estimating equations.
Results: The 226 primary cases were followed by 198 (49%) secondary SARS-CoV-2 infections among 404 household contacts. Age group-specific SIR among contacts ranged from 36% to 53%, with no differences by age. SIR was lower in primary cases age 12 to 17 years than from primary cases 18 to 49 years (risk ratio [RR] 0.42; 95% confidence interval [CI] 0.19-0.91). SIR was 55% and 45%, respectively, among primary case-contact pairs in the same versus different age group (RR 1.47; 95% CI 0.98-2.22). SIR was highest among primary case-contact pairs age ≥65 years (76%) and 5 to 11 years (69%). Among secondary SARS-CoV-2 infections, 19% were asymptomatic; there was no difference in the frequency of asymptomatic infections by age group.
Conclusions: Both children and adults can transmit and are susceptible to SARS-CoV-2 infection. SIR did not vary by age, but further research is needed to understand age-related differences in probability of transmission from primary cases by age.
 
Back
Top Bottom